CROCS Inc. (NASDAQ: CROX) is a story of the good, the bad, and the fugly. The maker of ugly fad shoes reported earnings after the close, which technically were no earnings at…
Douglas A. McIntyre Crocs, Inc. (CROX) is showing yet again that its growth days are history. The fad shoe maker has announced that it sold certain assets of its Foam Creations business unit in Quebec…
Douglas A. McIntyre As the markets went back to triple-digit losses, there were many more new stocks (and repeat performers) on the 52-week low club today. Many of these look just like an explosion in…
Crocs (CROX) Crocs may actually be moving into the stage where its price and market cap are so low that it could become a takeover target. After announcing awful quarterly numbers and…
Scripps (SSP) Newspaper stock takes big hit on earnings. Falls to $7.17 from 52-week high of $147.78. McClatchy Newspapers (MNI) Another newspaper company with problems. Sells down to $4.30 from 52-week high…
Crocs, Inc. (NASDAQ: CROX) just joined the category of stocks that the old term of "S.N.A.F.U." would apply to. The maker of the faddish and notoriously ugly shoes came out warned for…
Douglas A. McIntyre Since 2006, 24/7 Wall St. has scrutinized public companies on a regular basis, focusing on those with poor management and has suggested which big company CEOs needed to be replaced. Hector Ruiz…
While most of the investment community goes out breaking down earnings for major stocks, there is a huge interest in many of the cult stocks reporting earnings. Among the cult stocks we…
Fremont General (FMT) Down 50% today. Finally delisted. Hit bottom at $.26 against 52-week high of $13.80. Avnet (AVT) Warns on profits. Slips to $27.76 from 52-week high of $44.68. Kinetic Concepts…
The latest earnings news is a clear and definite indicator that the earnings damage from the current slowdown is unlike to take prisoner. Crocs (NASDAQ: CROX), the maker of odd-balls shoes and…
Douglas A. McIntyre Superior Offshore (DEEP) Company warns of liquidity problems. Down to $1.20 from 52-week high of $19.58. Medarex (MEDX) Pfizer ends joint drug trial. Sells off to $7.44 from 52-week high of $18.23.…
Below are the top analyst calls we are focusing on this Wednesday morning: AFLAC (NYSE: AFL) cut to Neutral from Buy at UBS. Crocs (NASDAQ: CROX) cut to Neutral from Overweight at…
You’ve always got some weak stocks that hit 52-week lows, particularly in a bear market. But there were many active stand-out names today that normally don’t appear on this screen. 3Com Corporation…
Crocs, Inc. (NASDAQ: CROX) has posted its fourth Quarter revenues rose more than 99% to $224.8 Million while its diluted EPS rose more than 73% to $0.45. First Call had estimates at…
Douglas A. McIntyre 2007 was one volatile year and for now it appears that will be the norm for at least the start of 2008. Everyone’s favorite market pundit or least liked pundit is obviously…